Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Extended utilization of transfer authorization in Investor AB

The Annual General Meeting of Investor 2019 decided to authorize the company’s Board to decide on the transfer of the company’s own shares in order to, among other things, secure costs for Investor’s long-term variable remuneration program for employees within Investor and for the issue of synthetic shares as part of the Board remuneration.  As previously communicated, the company’s Board has decided to utilize the authorization for these purposes. Due to the postponed Annual General Meeting the transfer period is extended to the Annual General Meeting on June 17, 2020. The transfer

Insr: Notice of Annual General Meeting May 20th, 2020

The Board of Directors of Insr Insurance Group ASA hereby convenes an Ordinary General Meeting. Time: 20 May 2020 at 14:00 (CET)Place: Insr's offices in Østensjøveien 43, 0667 Oslo.Due to Covid-19, and all shareholders are requested to attend by proxy and only the ones who have returned the attendance slip within the deadline will be able to attend the meeting. Please find more information in the attached document.For more information, please contactAnne B. KnudtzonSVP Business Controlling & Investor RelationsPhone: +47 926 10 606E-mail: anne.b.knudtzon@insr.io

YIT Corporation: Managers’ transactions – Tuomela

YIT Corporation                  Managers' transactions                            May 6, 2020 at 10:14 a.m.YIT Corporation: Managers’ transactions – Tuomela YIT Corporation has received the following notification: YIT Corporation - Managers' transactions ____________________________________________ Person subject to the notification requirement Name: Tuomela, Tiina Position: Member of the Board/Deputy member Issuer: YIT Corporation LEI: 529900M13GM4VSTE6W80 Notification type: INITIAL NOTIFICATION Reference number: 529900M13GM4VSTE6W80_20200505182936_48 _____

YIT Corporation: Managers’ transactions – Topolska

YIT Corporation                  Managers' transactions                            May 6, 2020 at 10:12 a.m.YIT Corporation: Managers’ transactions – Topolska YIT Corporation has received the following notification: YIT Corporation - Managers' transactions ____________________________________________ Person subject to the notification requirement Name: Topolska, Barbara Position: Member of the Board/Deputy member Issuer: YIT Corporation LEI: 529900M13GM4VSTE6W80 Notification type: INITIAL NOTIFICATION Reference number: 529900M13GM4VSTE6W80_20200505182936_51 _

YIT Corporation: Managers’ transactions – Pentti-von Walzel

YIT Corporation                  Managers' transactions                            May 6, 2020 at 10:10 a.mYIT Corporation: Managers’ transactions – Pentti-von Walzel YIT Corporation has received the following notification: YIT Corporation - Managers' transactions ____________________________________________ Person subject to the notification requirement Name: Pentti-von Walzel, Kristina Position: Member of the Board/Deputy member Issuer: YIT Corporation LEI: 529900M13GM4VSTE6W80 Notification type: INITIAL NOTIFICATION Reference number: 529900M13GM4VSTE6W80_

YIT Corporation: Managers’ transactions – Lehtinen

YIT Corporation                  Managers' transactions                            May 6, 2020 at 10:08 a.mYIT Corporation: Managers’ transactions – Lehtinen YIT Corporation has received the following notification: YIT Corporation - Managers' transactions ____________________________________________ Person subject to the notification requirement Name: Lehtinen, Olli-Petteri Position: Member of the Board/Deputy member Issuer: YIT Corporation LEI: 529900M13GM4VSTE6W80 Notification type: INITIAL NOTIFICATION Reference number: 529900M13GM4VSTE6W80_20200505182936_47

YIT Corporation: Managers’ transactions – Hyldmar

YIT Corporation                  Managers' transactions                            May 6, 2020 at 10:06 a.m.YIT Corporation: Managers’ transactions – Hyldmar YIT Corporation has received the following notification: YIT Corporation - Managers' transactions ____________________________________________ Person subject to the notification requirement Name: Hyldmar, Frank Position: Member of the Board/Deputy member Issuer: YIT Corporation LEI: 529900M13GM4VSTE6W80 Notification type: INITIAL NOTIFICATION Reference number: 529900M13GM4VSTE6W80_20200505182936_50 _____

Polygon appoints a new Director of International Sales

Polygon announced today the appointment of a new Director of International Sales – Hans Christian Sorensen.In recent years, Polygon has strengthened its international customer base. Many international customers appreciate that Polygon can deliver services in several countries.  To further strengthen our international presence and offer high quality services to our customer, the company has decided to appoint an International Sales Director who will focus on engaging the clients as well as to coordinate our sales and marketing efforts across boundaries. Hans-Christian has strong experience

Nixu Corporation Initiates a Cost Reduction Program to Address the Impact of the COVID-19

Nixu Corporation, Press release on May 6, 2020 at 10:05 AM EESTNixu Corporation estimates that the COVID-19 pandemic will lead to a situation where economic growth pace will slow sharply in 2020 and the economic impact will continue still in 2021. Although digitalization will progress strongly and the need for cybersecurity will only increase after the pandemic, Nixu estimates that its growth opportunities will be limited in the short term. For this reason, Nixu has decided in the short term to cut down on growth investments aimed at bringing very strong growth (during past years averaging

YIT Corporation: Managers’ transactions – Ehrnrooth

YIT Corporation                  Managers' transactions                            May 6, 2020 at 10:04 a.m.YIT Corporation: Managers’ transactions – Ehrnrooth YIT Corporation has received the following notification: YIT Corporation - Managers' transactions ____________________________________________ Person subject to the notification requirement Name: Ehrnrooth, Alexander Position: Member of the Board/Deputy member Issuer: YIT Corporation LEI: 529900M13GM4VSTE6W80 Notification type: INITIAL NOTIFICATION Reference number: 529900M13GM4VSTE6W80_20200505182936_49

YIT Corporation: Managers’ transactions – Heliövaara

YIT Corporation                  Managers' transactions                            May 6, 2020 at 10:02 a.m.YIT Corporation has received the following notification: YIT Corporation - Managers' transactions ____________________________________________ Person subject to the notification requirement Name: Heliövaara, Eero Position: Member of the Board/Deputy member Issuer: YIT Corporation LEI: 529900M13GM4VSTE6W80 Notification type: INITIAL NOTIFICATION Reference number: 529900M13GM4VSTE6W80_20200505182936_45 ____________________________________________

Wärtsilä publishes open access interactive map indicating potential of cost-optimal 100% renewable electricity systems

Wärtsilä Corporation, Trade press release, 6 May 2020 at 10 am EESTThe technology group Wärtsilä is today publishing on its website an extensive interactive map Atlas of 100% Renewable Energy on cost-optimal, 100% renewable electricity systems globally. The map provides valuable information on the potential of renewable energy in relation to geographical regions and their solar and wind conditions. Wärtsilä has modelled 145 countries and different regions of the world in one hour dispatch granularity to provide an illustrative guide as to the cost-optimal potential of developing 100%

YIT Corporation: Managers’ transactions – Kaukonen

YIT Corporation                  Managers' transactions                            May 6, 2020 at 10:00 a.m.YIT Corporation: Managers’ transactions – Kaukonen YIT Corporation has received the following notification: YIT Corporation - Managers' transactions ____________________________________________ Person subject to the notification requirement Name: Kaukonen, Harri-Pekka Position: Member of the Board/Deputy member Issuer: YIT Corporation LEI: 529900M13GM4VSTE6W80 Notification type: INITIAL NOTIFICATION Reference number: 529900M13GM4VSTE6W80_20200505182936_44

Correction: Terveystalo Group Interim report 1 January – 31 March 2020

The COVID-19 crisis impacts the business heavily in the short term Terveystalo Plc, Interim report, 6 May 2020 at 9:45 EESTIn the release published 6 May 2020 at 9:00 the full release attachment was missing from the English version. It is attached to this release.  This release is a summary of Terveystalo's Interim report 1 January – 31 March 2020. The full release is attached to this stock exchange release and is available on our website at: https://www.terveystalo.com/en/investors/Financial-information/. January–March 2020 in brief · Revenue decreased by 3.9 percent year-

NRC Group ASA - Appointed to a contract in Norway - NOK 39 million

Bane NOR has appointed NRC Bane AS, a company wholly owned by NRC Group ASA, to a power supply system contract on the railway connection between Alna and Etterstad. The contract is valued at approximately NOK 39 million and will involve rail services such as electro and groundwork. The work will commence in May 2020, and the project is scheduled for completion in January 2021. Closing date for submission of complaints is 10 days from today, and formal contractual signing can take place after this period at the earliest. For further information, please contact: Henning Olsen, CEO

C-RAD AB - Interim report January – March 2020

GROWTH AND POSITIVE RESULT DESPITE TURBULENT QUARTER FIRST QUARTER 2020      · Order intake amounted to 47.7 (47.8) MSEK, -3% in constant currencies · Order backlog amounted to 261.5 (201.2) MSEK · Revenue amounted to 51.8 (47.3) MSEK, corresponding to a 10% growth (7% in constant currencies) · Operating profit amounted to 1.0 (1.2) MSEK, corresponding to a margin of 1.9 (2.5) % · Net results after tax amounted 0.4 (0.8) MSEK · Result per share amounted to 0.01 (0.02) SEK Comments from Tim Thurn, CEO The first quarter of 2020 generated solid results, despite

Veoneer Begins Production of Technology Suite for Polestar 2

Stockholm, Sweden, May 6, 2020: The automotive technology company Veoneer, Inc. (NYSE: VNE and SSE: VNE SDB), launches its state-of-the-art suite of collision mitigation technology on the new fully electric Polestar 2.Veoneer begins production of its advanced sensing technology and software enabling the Polestar 2 to become a leader in the next generation of car safety. The system allows the Polestar 2 to gather information and data about its surroundings and the trajectory of vehicles around it to assist drivers to avoid potentially hazardous situations.  Key components of the

ORGANOCLICK AB (PUBL) PUBLISH INTERIM REPORT FOR Q1 2020

The first quarter of the year can be divided into two periods: before and after the COVID-19 outbreak in Europe. The year 2020 started well, with a strong order intake on the Swedish market as well as on our export markets - but since the corona virus hit us with force in the beginning of March, our export markets have stalled. The Swedish sales of ORGANOWOOD® timber and BIOkleen® maintenance products through retailers in the building and paint trade are still doing relatively well, while we are seeing increasing impact on the sales of OrganoTex® through sports and outdoor retailers. What

FDA grants MIV-818 Orphan Drug Designation for the treatment of hepatocellular carcinoma

Stockholm, Sweden — Medivir AB (Nasdaq Stockholm: MVIR) today announced that the U.S. Food and Drug Administration (FDA) has granted orphan drug designation (ODD) to MIV-818 for the treatment of patients with hepatocellular carcinoma (HCC), the most common type of primary liver cancer. FDA grants orphan status to drugs intended to treat rare diseases affecting fewer than 200,000 people in the U.S. The orphan designation provides certain benefits to drug developers, including tax credits for clinical trial expenditures, waived user fees for marketing applications, and eligibility for

2020 Bulkers Ltd. (2020) Conversion of index-linked charter hire for Bulk Sandefjord and Bulk Sydney

Hamilton, Bermuda, May 6, 2020 2020 Bulkers has converted the index-linked charter hire for Bulk Sandefjord and Bulk Sydney to fixed rate charter hire from June to December 2020 at US$14,378 per day, gross, and US$14,702 per day, gross, respectively. The vessels will in addition earn a profit share based on the fuel cost saving generated by the scrubbers. Following the conversion, the six vessels in operation today have fixed rate charter coverage for 1,384 days remaining in 2020 at a weighted average rate of US$19,303 per day. The fixed charter hire coverage covers all budgeted G&A,

INTERIM REPORT 1 JANUARY – 31 MARCH 2020

First QUARTER Interim (1 January – 31 March 2020) · Net sales for the quarter amounted to MSEK 50 (81). · Operating profit/loss before depreciation and amortisation (EBITDA) was MSEK 26 (-232). · Operating profit/loss (EBIT) was MSEK 7 (-251). · Loss before tax amounted to MSEK -7 (-294). · Loss after tax totalled MSEK -7 (-288), corresponding to SEK -0.21 (-8.61) per share. · Operating cash flow was MSEK 8 (40). · Production from Own wind power operations was 124 GWh (103). The increase was due to stronger wind conditions than in the preceding year. · Average

First participant enrolled in the clinical hepatic impairment study with Mangoral

Ascelia Pharma AB (publ) (ticker: ACE) (“Ascelia”) today announced that the first participant has been enrolled in the company’s clinical study with Mangoral in volunteers with different degrees of hepatic impairment. Results from this hepatic study could potentially enable the use also in Mangoral’s target population with impaired liver function.The overall objective of this special populations hepatic study is to assess the influence of hepatic impairment on the safety, pharmacokinetics and pharmacodynamics of the liver specific oral MRI contrast agent, Mangoral. Patients with moderate or

Farxiga approved in the US for the treatment of heart failure in patients with heart failure with reduced ejection fraction

6 May 2020 07:00 BST Farxiga approved in the US for the treatment of heart failurein patients with heart failure with reduced ejection fraction Farxiga is the first SGLT2 inhibitor proven to significantly reducethe risk of cardiovascular death and hospitalisation for heart failure AstraZeneca's Farxiga (dapagliflozin) has been approved in the US to reduce the risk of cardiovascular (CV) death and hospitalisation for heart failure in adults with heart failure (NYHA class II-IV) with reduced ejection fraction (HFrEF) with and without type-2 diabetes (T2D). The approval by the

There are no items matching the current filter
There are no more items matching the current filter
Back to top